1. Surveying the Safety of NOACs in the Real World

3. Program Goals

4. Introduction: Management of VTE

5. NOACs in VTE Setting: Transformation in Clinical Practice

6. Clinical Trials Data vs Real-World/ Registry Data

7. Real-World NOACs Database

8. Adherence to VKAs

9. Persistence With NOACs: Community Pharmacies Data

10. Persistence With Rivaroxaban The Dresden Non-interventional Anticoagulation Registry

11. NOACs Risk of Major Bleeding in VTE: Clinical Trials

12. XANTUS Rivaroxaban Registry

13. NOAC Trials: NOACs vs Warfarin Efficacy and Safety

14. NOACs Treatment Selection in VTE

15. NOACs Dose Reduction

16. Summary

17. Abbreviations

18. Abbreviations (cont)

19. References

20. References (cont)

21. References (cont)

22. References (cont)

23. References (cont)

24. References (cont)